Filtered By:
Management: Health Insurance
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 9039 results found since Jan 2013.
COVID-19 Vaccination Status Among Korean Pediatric Population With Comorbidities
J Korean Med Sci. 2023 Aug 14;38(32):e248. doi: 10.3346/jkms.2023.38.e248.ABSTRACTThe pediatric population with comorbidities is a high-risk group for severe coronavirus disease 2019 (COVID-19). As of January 2023, the COVID-19 vaccination rate for at least two doses among Korean children 5-11 years is low at 1.1%. We summarized the COVID-19 vaccination status for the pediatric population (5-17 years) with comorbidities through July 2022 using the National Health Insurance Service database. Pediatric patients with comorbidities had higher vaccination rates than the general pediatric population (2.4% vs. 1.1% in 5-11-year-o...
Source: J Korean Med Sci - August 15, 2023 Category: General Medicine Authors: Areum Shin Dong Wook Kim Young-Eun Kim Doo Ri Kim Jaehun Jung Yae-Jean Kim Source Type: research
Sickle cell disease in Ontario, Canada: an epidemiologic profile based on health administrative data
CMAJ Open. 2023 Aug 15;11(4):E725-E733. doi: 10.9778/cmajo.20220145. Print 2023 Jul-Aug.ABSTRACTBACKGROUND: The number of patients with sickle cell disease in Ontario, Canada, is unknown. In the absence of a formal registry, we performed a study to determine an approximate census via analysis of health administrative databases.METHODS: We identified Ontario patients with a diagnosis of sickle cell disease through queries of the Discharge Abstract Database, National Ambulatory Care Reporting System and Newborn Screening Ontario database. The period of inquiry was Apr. 1, 2007, through Mar. 31, 2017. We identified repeat int...
Source: cmaj - August 15, 2023 Category: General Medicine Authors: Jacob Pendergrast Lanre Tunji Ajayi Eliane Kim Michael A Campitelli Erin Graves Source Type: research
COVID-19 Vaccination Status Among Korean Pediatric Population With Comorbidities
J Korean Med Sci. 2023 Aug 14;38(32):e248. doi: 10.3346/jkms.2023.38.e248.ABSTRACTThe pediatric population with comorbidities is a high-risk group for severe coronavirus disease 2019 (COVID-19). As of January 2023, the COVID-19 vaccination rate for at least two doses among Korean children 5-11 years is low at 1.1%. We summarized the COVID-19 vaccination status for the pediatric population (5-17 years) with comorbidities through July 2022 using the National Health Insurance Service database. Pediatric patients with comorbidities had higher vaccination rates than the general pediatric population (2.4% vs. 1.1% in 5-11-year-o...
Source: J Korean Med Sci - August 15, 2023 Category: General Medicine Authors: Areum Shin Dong Wook Kim Young-Eun Kim Doo Ri Kim Jaehun Jung Yae-Jean Kim Source Type: research
Sickle cell disease in Ontario, Canada: an epidemiologic profile based on health administrative data
CMAJ Open. 2023 Aug 15;11(4):E725-E733. doi: 10.9778/cmajo.20220145. Print 2023 Jul-Aug.ABSTRACTBACKGROUND: The number of patients with sickle cell disease in Ontario, Canada, is unknown. In the absence of a formal registry, we performed a study to determine an approximate census via analysis of health administrative databases.METHODS: We identified Ontario patients with a diagnosis of sickle cell disease through queries of the Discharge Abstract Database, National Ambulatory Care Reporting System and Newborn Screening Ontario database. The period of inquiry was Apr. 1, 2007, through Mar. 31, 2017. We identified repeat int...
Source: cmaj - August 15, 2023 Category: General Medicine Authors: Jacob Pendergrast Lanre Tunji Ajayi Eliane Kim Michael A Campitelli Erin Graves Source Type: research
COVID-19 Vaccination Status Among Korean Pediatric Population With Comorbidities
J Korean Med Sci. 2023 Aug 14;38(32):e248. doi: 10.3346/jkms.2023.38.e248.ABSTRACTThe pediatric population with comorbidities is a high-risk group for severe coronavirus disease 2019 (COVID-19). As of January 2023, the COVID-19 vaccination rate for at least two doses among Korean children 5-11 years is low at 1.1%. We summarized the COVID-19 vaccination status for the pediatric population (5-17 years) with comorbidities through July 2022 using the National Health Insurance Service database. Pediatric patients with comorbidities had higher vaccination rates than the general pediatric population (2.4% vs. 1.1% in 5-11-year-o...
Source: J Korean Med Sci - August 15, 2023 Category: General Medicine Authors: Areum Shin Dong Wook Kim Young-Eun Kim Doo Ri Kim Jaehun Jung Yae-Jean Kim Source Type: research
Cost and effectiveness analyses of the anti-osteoporosis medication in patients with hip fracture in Taiwan: A population-based national claims database analysis
CONCLUSION: Overall, under Taiwan's national health insurance, the use of AOMs is cost-saving, especially in the population aged ≥70 years. The finding of this research was valuable for policymakers in considering healthcare policy promotion and resource allocation in the future.PMID:37574339 | DOI:10.1016/j.jfma.2023.07.018
Source: J Formos Med Assoc - August 13, 2023 Category: General Medicine Authors: Chen-Yu Wang Chih-Hsing Wu Ho-Min Chen Jou-Wei Lin Chih-Cheng Hsu Yin-Fan Chang Ta-Wei Tai Shau-Huai Fu Jawl-Shan Hwang Source Type: research
Chronic Periodontitis and the Potential Likelihood of Gastric Cancer: A Nested Case-Control Study in the Korean Population Utilizing a National Health Sample Cohort
In conclusion, CP may be a potential risk factor for gastric cancer development in the Korean population. Regular screening for gastric cancer may be necessary for high-risk individuals, specifically men aged <65 years with a history of CP.PMID:37568790 | DOI:10.3390/cancers15153974
Source: Cancer Control - August 12, 2023 Category: Cancer & Oncology Authors: Mi Jung Kwon Ho Suk Kang Min-Jeong Kim Nan Young Kim Hyo Geun Choi Hyun Lim Source Type: research
Drug dispensation at both community and hospital pharmacy the highly active antiretrovirals example
CONCLUSION: This study presents a complete inventory of the dual delivery system for antiretroviral therapies. Hospital and community therefore remain complementary to welcome outptients who will seek different delivery methods there. Little known to patients and professionals, this dual delivery system generates complexities at the stages of prescription, dispensing and reimbursement. It only concerns a minority of patients and its benefit for health insurance seems uncertain.PMID:37567558 | DOI:10.1016/j.pharma.2023.08.001
Source: Annales Pharmaceutiques Francaises - August 11, 2023 Category: Drugs & Pharmacology Authors: Laure Tribaudeau Blandine Juillard-Condat Florence Taboulet Fr éderic Eyvrard Source Type: research
Outpatient and "Admission-Substituting" Interventions in Vascular Surgery - What is Feasible and Where are the Limits? Previous and New Legal Requirements and their Implementation in Practice
CONCLUSION: The potential to transform inpatient services into the outpatient setting of service provision is realisable in vascular surgery in the core areas of varicose vein surgery, shunt surgery and peripheral interventional procedures under specific conditions.PMID:37562434 | DOI:10.1055/a-2100-1458
Source: Zentralblatt fur Chirurgie - August 10, 2023 Category: Surgery Authors: Udo Barth Martin Lehmann J örg Tautenhahn Frank Meyer Zuhir Halloul Source Type: research
Antidepressants and the Risk of Ischemic Stroke in Older Adults According to the Degree of Serotonin Reuptake Inhibition: A Retrospective Cohort Study
CONCLUSION: The use of strong and intermediate SRIs should be considered carefully in older adult patients, especially when high-dose antidepressants are prescribed even for a short duration.PMID:37562992 | DOI:10.1016/j.jagp.2023.07.013
Source: Am J Geriatr Psychia... - August 10, 2023 Category: Geriatrics Authors: Kyoung-Eun Kwon Bo Ram Yang Mi-Sook Kim Byung-Joo Park Joongyub Lee Sun-Young Jung Source Type: research
